Brand News

Trend Pieces & Editorial

Updates About Industry

Regulation

Oops, Minnesota Accidentally Legalized THC-Spiked Seltzer

Idaho outlawing pet CBD products starting Nov. 1

The sale of pet CBD and other hemp-derived products in Idaho will be prohibited on Nov. 1.

The Idaho State Department of Agriculture has deemed such products illegal as they’ve grown in popularity across the state, according to Boise TV station KBOI.

“These products are considered adulterated,” said Chanel Tewalt, the agency’s deputy director.

“They’re considered that way at the federal level and the state level.”

What Oregon’s Ban on Synthetic Cannabinoids Means for the Industry

• Regulators have banned the sale of all artificially derived cannabinoids outside the state’s regulated cannabis market. Industry stakeholders explain why they think this is problematic.
• Regulators in Oregon, concerned about the potential of harmful byproducts in artificially derived cannabinoids—and particularly worried about the unregulated delta-8 products that were appearing on the shelves of grocery stores and gas stations across the state—banned the sale of all synthetic cannabinoids on the open market as of July 1, 2022.
• Products containing artificially derived cannabinoids may still be sold by cannabis retailers licensed through the Oregon Liquor and Cannabis Commission (OLCC) until July 1, 2023, at which point the products must be approved by the U.S. Food and Drug Administration (FDA) in order to remain on dispensary shelves.

Key lawmaker co-sponsors CBD supplements bill

• The chair of the House Agriculture Committee is the latest co-sponsor of a bill that would legalize hemp-derived CBD in dietary supplements, drawing praise from an industry organization that has lobbied vigorously in support of H.R. 841.
• Rep. David Scott, a Democrat from Georgia, co-sponsored H.R. 841 on Aug. 26. The bill has more than 40 co-sponsors following its introduction last year by Rep. Kurt Schrader, a Democrat from Oregon.
• “We’re deeply grateful to Chairman Scott for his leadership and his responsiveness to our industry’s concerns,” shared Jonathan Miller, General Counsel to the U.S. Hemp Roundtable and a member-in-charge at the law firm Frost Brown Todd LLC. “This is an important signal that FDA’s policy toward CBD will come under severe scrutiny during the 2023 Farm Bill discussions, and we are very hopeful that the resolution will be a regulatory pathway for the sale of non-intoxicating ingestible hemp extracts.”

AHPA’s Updated Hemp Lexicon Seeks To Shed Light On ‘Full Spectrum’ Question

• The American Herbal Products Association has released a new guidance document that seeks to bring clarity to hemp nomenclature, in particular what ought to be meant by the terms ‘broad spectrum’ and ‘full spectrum’ extracts.

Costa Rica Announces Bill to Allow Recreational Marijuana

• The President of Costa Rica, Rodrigo Chaves, announced a project to approve recreational marijuana. During the official act commemorating the first 100 days of his administration, the President announced the initiative.
• According to Chaves, the initiative will be sent to Congress for discussion. Likewise, He also affirmed that his administration would soon publish the regulation on medical cannabis, which the previous Congress approved.
• “We have prepared the regulation of industrial hemp for medicinal use, and we will promote the bill for the legalization of marihuana for recreational use,” said the president in his speech.

The Latest

Category & Research Trends

Study Points To Potential Benefits Of CBD For Menopausal Women

Research out of Rutgers University in the USA suggests cannabidiol (CBD) could be of benefit to menopausal and postmenopausal women.

In their preclinical study, the Rutgers researchers found when estrogen-deficient mice were fed CBD over 18 weeks, they showed significant improvement in several important areas; including an increase in bone density, less gut inflammation and the mice burned more energy. The mice not treated developed symptoms that resembled those of postmenopausal human females.

Dolphin Study Identifies Hitherto Unknown Endocannabinoid

• In a 2019 paper, researchers at the University of Illinois reported on recent discoveries of another four endocannabinoids and their derivatives, all synthesized in the body from two omega-3 essential fatty acids found primarily in fish and supplements.
• Which brings us to the latest discovery, a molecule called pentadecanoylcarnitine (PDC).
• It binds with both CB1 and CB2, among other receptors, and may play a role in a variety of physiological processes related to the regulation of inflammation, pain, mood, and sleep.